Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study
- PMID: 36793078
- PMCID: PMC9930214
- DOI: 10.1186/s12962-023-00426-y
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study
Abstract
Background: Cost-effectiveness analysis plays a key role in evaluating health systems and services. Coronary artery disease is one of the primary health concerns worldwide. This study sought to compare the cost-effectiveness of Coronary Arteries Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) through drug stent using Quality-Adjusted Life Years (QALY) index.
Methods: This is a cohort study involving all patients undergoing CABG and PCI through drug stent in south of Iran. A total of 410 patients were randomly selected to be included in the study. Data were gathered using SF-36, SAQ and a form for cost data from the patients' perspective. The data were analyzed descriptively and inferentially. Considering the analysis of cost-effectiveness, Markov Model was initially developed using TreeAge Pro 2020. Both deterministic and probabilistic sensitivity analyses were performed.
Results: Compared with the group treated with PCI, the total cost of interventions was higher in the CABG group ($102,103.8 vs $71,401.22) and the cost of lost productivity ($20,228.68 vs $7632.11), while the cost of hospitalization was lower in CABG ($67,567.1 vs $49,660.97). The cost of hotel stay and travel ($6967.82 vs $2520.12) and the cost of medication ($7340.18 vs $11,588.01) was lower in CABG. From the patients' perspective and SAQ instrument, CABG was cost-saving, with a reduction of $16,581 for every increase in effectiveness. Based on patients' perspective and SF-36 instrument, CABG was cost-saving, with a reduction of $34,543 for every increase in effectiveness.
Conclusion: In the same indications, CABG intervention leads to more resource savings.
Keywords: Costs-effectiveness; Markov model; Quality-Adjusted Life Years; Seattle angina questionnaire; Short form-36 questionnaire.
© 2023. The Author(s).
Conflict of interest statement
There is no competing interest related to this study.
Figures
Similar articles
-
Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.Heart. 2015 Dec;101(24):1980-8. doi: 10.1136/heartjnl-2015-307578. Epub 2015 Nov 9. Heart. 2015. PMID: 26552756 Clinical Trial.
-
Cost-Effectiveness of Percutaneous Coronary Intervention Versus Bypass Surgery for Patients With Left Main Disease: Results From the EXCEL Trial.Circ Cardiovasc Interv. 2022 Jul;15(7):e011981. doi: 10.1161/CIRCINTERVENTIONS.122.011981. Epub 2022 Jul 19. Circ Cardiovasc Interv. 2022. PMID: 35861797
-
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1. Circulation. 2014. PMID: 25085960 Clinical Trial.
-
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071. J Am Coll Cardiol. 2018. PMID: 30025574
-
Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trial.Cost Eff Resour Alloc. 2018 Nov 3;16:55. doi: 10.1186/s12962-018-0158-z. eCollection 2018. Cost Eff Resour Alloc. 2018. PMID: 30410425 Free PMC article. Review.
Cited by
-
Do coronary stent policies affect the cost-effectiveness of percutaneous coronary intervention among patients with acute coronary syndrome in Shanghai? A retrospective cohort study based on real-world and propensity score-matched data.BMJ Open. 2024 Jun 19;14(6):e083456. doi: 10.1136/bmjopen-2023-083456. BMJ Open. 2024. PMID: 38904127 Free PMC article.
-
Treatment charges for acute coronary syndrome: A retrospective analysis.Proc (Bayl Univ Med Cent). 2025 Jul 25;38(5):617-621. doi: 10.1080/08998280.2025.2530809. eCollection 2025. Proc (Bayl Univ Med Cent). 2025. PMID: 40821465 Free PMC article.
-
Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the GBD Study 2019.J Am Heart Assoc. 2024 Jan 16;13(2):e030165. doi: 10.1161/JAHA.123.030165. Epub 2024 Jan 16. J Am Heart Assoc. 2024. PMID: 37956220 Free PMC article.
References
-
- Ahmadi AM, Imami Razavi SA, Yaqubi Kalateh Rahman M. Comparison of cost-benefit of transplantation of hemograft heart valves and mechanical heart valves using caliber index in Imam Khomeini Hospital from 2001 to 2006 [M.Sc.]. Tehran: Iran University of Medical Sciences; 2007. [In Persian]
-
- Fayyazi P, Sayadi N, Gheibizadeh M. Comparison of quality of life, before and after open heart surgery. Zahedan Med Sci Res. 2011;13(7):1–4.
LinkOut - more resources
Full Text Sources
Miscellaneous